Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II. [PDF]
Zhang C +13 more
europepmc +1 more source
Rescue of neurologic disease in mucopolysaccharidosis type II mice via AAV-mediated liver delivery of brain-penetrating iduronate-2-sulfatase. [PDF]
Jin X +15 more
europepmc +1 more source
Novel Phenotypic Insights into the <i>IDS</i> c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts. [PDF]
Beauregard-Lacroix É +6 more
europepmc +1 more source
Case report of neuronopathic mucopolysaccharidosis type II: Early intracerebroventricular enzyme replacement therapy and hematopoietic cell transplantation with developmental outcomes up to 5 years of age. [PDF]
Ikari A, Hama A, Okuyama T.
europepmc +1 more source
Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. [PDF]
Al-Hertani W +6 more
europepmc +1 more source
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond. [PDF]
Zanetti A, Tomanin R.
europepmc +1 more source
Oral trehalose improves histological and behavior symptoms of mucopolysaccharidosis type II in iduronate 2-sulfatase deficient mice. [PDF]
Lee H +8 more
europepmc +1 more source
Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants. [PDF]
Zanetti A, D'Avanzo F, Tomanin R.
europepmc +1 more source
Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report. [PDF]
Hattori Y +5 more
europepmc +1 more source
Heparan sulfate in cerebrospinal fluid as a biomarker to assess disease severity and for treatment monitoring in patients with Mucopolysaccharidosis Type II: a position statement. [PDF]
Giugliani R +7 more
europepmc +1 more source

